Bharat Parenterals Limited (BOM:541096)

India flag India · Delayed Price · Currency is INR
973.90
-11.85 (-1.20%)
At close: Apr 21, 2025
-36.76%
Market Cap 6.45B
Revenue (ttm) 3.06B
Net Income (ttm) -82.13M
Shares Out 6.52M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend 1.00 (0.10%)
Ex-Dividend Date Jun 25, 2024
Volume 434
Average Volume 2,909
Open 972.45
Previous Close 985.75
Day's Range 968.00 - 1,015.00
52-Week Range 802.00 - 1,870.00
Beta 0.85
RSI 43.64
Earnings Date May 20, 2025

About Bharat Parenterals

Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India. The company provides products in the areas of antibiotics, anti-retroviral, antiprotozoal/anthelmintic, respiratory, antiallergic/anti-histaminic/anticold, cleansing agents/skin infections, cardiovascular systems, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastrointestinal tract/alimentary systems, anti-inflammatory/anti-pyretic/analgesics, supplements, central nervous syste... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 363
Stock Exchange Bombay Stock Exchange
Ticker Symbol 541096
Full Company Profile

Financial Performance

In 2023, Bharat Parenterals's revenue was 2.59 billion, an increase of 18.29% compared to the previous year's 2.19 billion. Earnings were 145.17 million, a decrease of -7.62%.

Financial Statements

News

There is no news available yet.